Ember Therapeutics (OP-1 product and related assets) is Biotechnology in United States that focus on related assets business. They cover business area such as developer, neuromusculoskeletal technology, use, orthopedic bone application, family, related asset, treatment technology, bone repair, regeneration.
-
Related Assets
-
One World Trade Center
85th Floor
New York, NY 10007
United States
Private
developerneuromusculoskeletal technologyuseorthopedic bone applicationfamilyrelated assettreatment technologybone repairregeneration
* We use standard office opening hours in near Ember Therapeutics (OP-1 product and related assets)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ember Therapeutics (OP-1 Product And Related Assets) is Biotechnology business from United States that founded in - ( years old in ), Ember Therapeutics (OP-1 product and related assets) business is focusing on Related Assets.
Ember Therapeutics (OP-1 product and related assets) headquarter office and corporate office address is located in One World Trade Center 85th Floor New York, NY 10007 United States.
Ember Therapeutics (OP-1 product and related assets) was founded in United States.
In , Ember Therapeutics (OP-1 product and related assets) is currently focus on related assets sector.
Above is snippet of Google Trends for "related assets" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ember Therapeutics (OP-1 product and related assets), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
